In greater than 95% of CML, there is a consistent presence of BCR-ABL1 fusion gene located in the Philadelphia (Ph) chromosome resulting from chromosomal translocation t(9; 22)(q34;q11.2). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.